Skip Navigation
Skip to contents

Endocrinol Metab : Endocrinology and Metabolism

clarivate
OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
2 "Won Woo Lee"
Filter
Filter
Article type
Keywords
Publication year
Authors
Funded articles
Review Article
Thyroid
2025 Korean Thyroid Association Management Guidelines for Radioactive Iodine Therapy in Patients with Hyperthyroidism
Kyeong Jin Kim, Eyun Song, Mijin Kim, Hyemi Kwon, Eu Jeong Ku, Hyun Woo Kwon, Jee Hee Yoon, Eun Kyung Lee, Won Woo Lee, Young Joo Park, Dong-Jun Lim, Sun Wook Kim, Ho-Cheol Kang, Jae Hoon Chung, Tae Yong Kim, Sin Gon Kim, Dong Gyu Na, Jee Soo Kim
Endocrinol Metab. 2025;40(3):342-356.   Published online June 24, 2025
DOI: https://doi.org/10.3803/EnM.2025.2464
  • 10,404 View
  • 377 Download
  • 1 Web of Science
  • 1 Crossref
AbstractAbstract PDFPubReader   ePub   
Hyperthyroidism is a condition marked by excessive thyroid hormone production, most commonly due to Graves’ disease. Treatment options include antithyroid drugs (ATD), radioactive iodine (RAI) therapy, and thyroidectomy. To develop standardized clinical recommendations for RAI therapy with a focus on safety, efficacy, and monitoring, the Korean Thyroid Association formed a task force to create evidence-based guidelines. Six key clinical questions were identified through expert consensus, and a systematic literature review from 2013 to 2022 was conducted. Clinical indications for RAI therapy were categorized into three groups: strongly recommended, may be considered, and not recommended. A fixed dose of 10 to 15 mCi is recommended. Although a strict low-iodine diet is unnecessary, iodine-rich foods should be avoided for at least 1 week before treatment. ATD should be stopped 3 to 7 days before RAI and may be resumed in select cases. Prophylactic glucocorticoids are recommended for patients with mildly active thyroid eye disease and may be considered for others at risk. Thyroid function should be monitored at 4–6 weeks post-treatment, every 2–3 months until stabilized, and then every 6–12 months. These guidelines highlight recent advances and underscore the importance of individualized treatment based on clinical features, comorbidities, and patient preferences in Korea.

Citations

Citations to this article as recorded by  
  • Outcome of MRI-Guided Single-Dose Iodine-131 for Graves’ Hyperthyroidism with Large Goiter
    Shangcheng Yan, Xiansheng Chen, Bing Yan, Xin Li, Zhen Cao, Pan Zhang, Yajun Wang, Wenmei Guo, Ziwen Liu
    Annals of Nuclear Medicine.2026;[Epub]     CrossRef
Close layer
Original Article
Thyroid
Association between Thyroid Function and Heart Rate Monitored by Wearable Devices in Patients with Hypothyroidism
Ki-Hun Kim, Juhui Lee, Chang Ho Ahn, Hyeong Won Yu, June Young Choi, Ho-Young Lee, Won Woo Lee, Jae Hoon Moon
Endocrinol Metab. 2021;36(5):1121-1130.   Published online October 21, 2021
DOI: https://doi.org/10.3803/EnM.2021.1216
  • 12,420 View
  • 206 Download
  • 8 Web of Science
  • 8 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Heart rate (HR) monitored by a wearable device (WD) has demonstrated its clinical feasibility for thyrotoxicosis subjects. However, the association of HR monitored by wearables with hypothyroidism has not been examined. We assessed the association between serum thyroid hormone concentration and three WD-HR parameters in hypothyroid subjects.
Methods
Forty-four subjects scheduled for radioactive iodine therapy (RAI Tx) after thyroid cancer surgery were included. Thirty subjects were prepared for RAI Tx by thyroid hormone withdrawal (hypothyroidism group) and 14 subjects by recombinant human thyrotropin (control group). Three WD-HR parameters were calculated from the HR data collected during rest, during sleep, and from 2:00 AM to 6:00 AM, respectively. We analyzed the changes in conventionally measured resting HR (On-site rHR) and WDHR parameters relative to thyroid hormone levels.
Results
Serum free thyroxine (T4) levels, On-site rHR, and WD-HR parameters were lower in the hypothyroid group than in the control group at the time of RAI Tx. WD-HR parameters also reflected minute changes in free T4 levels. A decrease in On-site rHR and WD-HR parameters by one standard deviation (On-site rHR, approximately 12 bpm; WD-HR parameters, approximately 8 bpm) was associated with a 0.2 ng/dL decrease in free T4 levels (P<0.01) and a 2-fold increase of the odds ratio of hypothyroidism (P<0.01). WD-HR parameters displayed a better goodness-of-fit measure (lower quasi-information criterion value) than On-site rHR in predicting the hypothyroidism.
Conclusion
This study identified WD-HR parameters as informative and easy-to-measure biomarkers to predict hypothyroidism.

Citations

Citations to this article as recorded by  
  • Cost-effectiveness Analysis Comparing Conventional and Digital Software Supported Management for Hypothyroidism
    Jung Hyun Kim, Jaeyong Shin, Man S Kim, Jae Hoon Moon
    The Journal of Clinical Endocrinology & Metabolism.2025; 110(6): 1596.     CrossRef
  • An explainable non-invasive hybrid machine learning framework for accurate prediction of thyroid-stimulating hormone levels
    Areej Mohammed, Hussam Alshraideh, Munir Abu-Helalah, Abdulrahim Shamayleh
    Computers in Biology and Medicine.2025; 189: 109974.     CrossRef
  • Application progress of artificial intelligence in managing thyroid disease
    Qing Lu, Yu Wu, Jing Chang, Li Zhang, Qing Lv, Hui Sun
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • A Digital Software Support Platform for Hyperthyroidism Management in South Korea: Markov Simulation Model-Based Cost-Effectiveness Analysis
    Jung Hyun Kim, Jaeyong Shin, Man S Kim, Jae Hoon Moon
    JMIR mHealth and uHealth.2025; 13: e56738.     CrossRef
  • Application of wearables for remote monitoring of oncology patients: A scoping review
    Katharina Cloß, Marlo Verket, Dirk Müller-Wieland, Nikolaus Marx, Katharina Schuett, Edgar Jost, Martina Crysandt, Fabian Beier, Tim H Brümmendorf, Guido Kobbe, Julia Brandts, Malte Jacobsen
    DIGITAL HEALTH.2024;[Epub]     CrossRef
  • Association between resting heart rate and low natural killer cell activity: a cross-sectional study
    Hyoju Oh, A-Ra Cho, Joo-Hwan Jeon, Eunkyung Suh, Junhyung Moon, Baek Hwan Cho, Yun-Kyong Lee
    Frontiers in Immunology.2024;[Epub]     CrossRef
  • Thyroid hormone action during GABAergic neuron maturation: The quest for mechanisms
    Sabine Richard, Juan Ren, Frédéric Flamant
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • A machine learning-assisted system to predict thyrotoxicosis using patients’ heart rate monitoring data: a retrospective cohort study
    Kyubo Shin, Jongchan Kim, Jaemin Park, Tae Jung Oh, Sung Hye Kong, Chang Ho Ahn, Joon Ho Moon, Min Joo Kim, Jae Hoon Moon
    Scientific Reports.2023;[Epub]     CrossRef
Close layer

Endocrinol Metab : Endocrinology and Metabolism
TOP